Evaluation of an orthogonal pooling strategy for rapid high-throughput screening of proteases

Assay and Drug Development Technologies

Volumn 6, Issue 3, 2008, Pages 395-405

  Motlekar, Nuzhat ^a   Diamond, Scott L ^a   Napper, Andrew D ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN B INHIBITOR; CYSTEINE; DITHIOTHREITOL; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PROTEINASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HIGH THROUGHPUT SCREENING; IC 50; VALIDATION STUDY; DRUG ANTAGONISM; HUMAN;

CATHEPSIN B; DITHIOTHREITOL; HUMANS; PROTEASE INHIBITORS;

EID: 51149121262     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2007.110     Document Type: Article

References (31)

1. Penn Center for Molecular Discovery: [online]. http://www.seas.upenn.edu/ ~pcmd/ (last accessed January 15, 2008).
2. Devlin JJ, Liang A, Trinh L, Polokoff MA, Senator D, Zheng W, et al.: High capacity screening of pooled compounds: identification of the active compound without reassay of pool members. Drug Dev Res 1996;37:80-85.
3. Hann M, Hudson B, Lewell X, Lifely R, Miller L, Ramsden N: Strategic pooling of compounds for high-throughput screening. J Chem Inform Comput Sci 1999;39:897-902.
4. Ferrand S, Schmid A, Engeloch C, Glickman JF: Statistical evaluation of a self-deconvoluting matrix strategy for high-throughput screening of the CXCR3 receptor. Assay Drug Dev Technol 2005;3:413-424.
5. Frlan R, Gobec S: Inhibitors of cathepsin B. Curr Med Chem 2006;13:2309-2327.
6. Stoka V, Turk B, Turk V: Lysosomal cysteine proteases: structural features and their role in apoptosis. IUBMB Life 2005;57:347-353.
7. Turk B, Stoka V, Rozman-Pungercar J, Cirman T, Droga-Mazovec G, Oreic K, et al.: Apoptotic pathways: involvement of lysosomal proteases. Biol Chem 2002;383:1035-1044.
8. Jedeszko C, Sloane BF: Cysteine cathepsins in human cancer. Biol Chem 2004;385:1017-1027.
9. Michaud S, Gour BJ: Cathepsin B inhibitors as potential anti-metastatic agents. Expert Opin Ther Patents 1998;8:645-672.
10. Schmitt M, Janicke F, Graeff H: Tumor-associated proteases. Fibrinolysis 1992;6:3-26.
11. Vasiljeva O, Reinheckel T, Peters C, Turk D, Turk V, Turk B: Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr Pharm Design 2007;13:387-403.
12. Schornberg K, Matsuyama S, Kabsch K, Delos S, Bouton A, White J: Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol 2006;80:4174-4178.
13. Haagmans BL, Osterhaus ADME: Coronaviruses and their therapy. Antiviral Res 2006;71:397-403.
14. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM: Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 2005;308:1643-1645.
15. BioFocus DPI: [online]. http://mlsmr.glpg.com/MLSMR_HomePage/ (last accessed January 15, 2008).
16. Baricos W, Zhou Y, Mason R, Barrett A: Human kidney cathepsins B and L. Biochem J 1998;252:301-304.
17. Barrett A, Kembhavi A, Brown M, Kirschke H, Knight G, Tamai M, Hanada K: L-trans-Epoxysuccinyl-leucylamido(4-guanidini)butane (E64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J 1982;201:189-198.
18. Penn Center for Molecular Discovery: Cathepsin B Inhibitor Series SAR Studies [online]. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=523 (last accessed January 15, 2008).
19. Penn Center for Molecular Discovery: Cathepsin B [online]. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=453 (last accessed January 15, 2008).
20. Penn Center for Molecular Discovery: Cathepsin B compound mixture screening [online]. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=488 (last accessed January 15, 2008).
21. Crowe A, Ballatore C, Hyde E, Trojanowski JQ, Lee VM: High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation. Biochem Biophys Res Commun 2007;358:1-6.
22. 2 Generation in 0.5 mM DTT [online]. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=682 (last accessed January 15, 2008).
23. Myers MC, Napper A, Motlekar N, Shah P, Chiu CH, Beavers MP, et al.: Identification and characterization of 3-substituted pyrazolyl esters as alternate substrates for cathepsin B: the confounding effects of DTT and cysteine in biological assays. Bioorg Med Chem Lett 2007;17:4761-4766.
24. Penn Center for Molecular Discovery: Cathepsin S [online]. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=501 (last accessed January 15, 2008).
25. Penn Center for Molecular Discovery: Cathepsin G [online]. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=581 (last accessed January 15, 2008).
26. Penn Center for Molecular Discovery: Complement Factor C1 [online]. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=538 (last accessed January 15, 2008).
27. Penn Center for Molecular Discovery: Complement factor C1s IC50 from mixture screen [online]. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=787 (last accessed January 15, 2008).
28. Penn Center for Molecular Discovery: Factor XIa Mixture HTS [online]. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=680 (last accessed January 15, 2008).
29. Penn Center for Molecular Discovery: Factor XIa Dose Response Confirmation [online]. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=679 (last accessed January 15, 2008).
30. Penn Center for Molecular Discovery: Factor XIIa Mixture HTS [online]. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=684 (last accessed January 15, 2008).
31. Penn Center for Molecular Discovery: Factor XIIa Dose Response Confirmation [online]. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=716 (last accessed January 15, 2008).